Oncology News

  • Survival After Breast Cancer 'Unaffected by BRCA Status' The likelihood that young women survive primary breast cancer is unaffected by whether or not they carry mutations in the BRCA gene, say UK researchers in a 10-year follow-up study.
  • GICS Question Over Ramucirumab in First-Line Gastric Cancer In combination with chemotherapy, ramucirumab improved progression-free survival but not overall survival or response rate in advanced gastric or gastroesophageal junction cancers.
  • MGUS in 3% of Population: What to Do? Evidence for clinical practice and follow-up is limited, and experts offer suggestions based on the literature and their own practice at the Mayo Clinic.
  • Experts Welcome Adjuvant Nivolumab for Melanoma The PD-1 inhibitor nivolumab was recently approved by the FDA for adjuvant use in completely resected stage III or IV melanoma, a move welcomed by experts in the field.


Today on Medscape

Top Stories from Across Medicine

Top Medical News from Across Medscape

  • Antibiotics, Antidepressants Dominate New FDA Watch ListPresence on list does not mean a drug has been linked to a risk, only that new safety information is available or potential risk has been identified and further review will be or has been completed.
  • Doctors Underdiagnosing Flu Among Older PatientsPatients over age 65 who are hospitalized for influenza-like illness were less likely to receive diagnostic tests from providers than were younger patients, a new study found.
  • Propranolol May Fill 'Dire' Treatment Need for PTSDPatients with posttraumatic stress disorder (PTSD) who actively recalled their traumatic event under the influence of propranolol showed a substantial decrease in symptom ratings.
  • More Evidence Links Gum Disease to Stroke RiskA new study shows a relationship between severity of gum disease and increasing future stroke risk, and conversely that regular dental care was linked to a lower stroke risk.


Business of Medicine

Advisory Board

Medscape Editor-in-Chief

  • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Executive Vice President and Professor of Molecular Medicine, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape
more information